The signaling pathways that may modulate the pathogenesis of diseases induced by expanded polyglutamine proteins are not well understood. model of neurodegeneration (spinocerebellar ataxia 1, or SCA-1).Taken together, our data implicate activated p38MAPK in disease progression and suggest that its inhibition may represent a rational strategy for therapeutic intervention in the polyglutamine disorders
International audiencePolyglutamine diseases, including Huntington's disease , designate a group of ...
Polyglutamine expansion disorders are progressive neurodegenerative diseases that are caused by the ...
Mammalian p38 mitogen-activated protein kinases (MAPKs) are activated by a wide range of cellular st...
The signaling pathways that may modulate the pathogenesis of diseases induced by expanded polyglutam...
<p>Activation p38MAPK signaling is counteracted by PKCι-mediated ERK activation in expanded polyglut...
The history of polyglutamine diseases dates back approximately 20 years to the discovery of a polygl...
AbstractThe mechanisms of neurodegeneration in the CAG repeat polyglutamine diseases, including Spin...
AbstractNine inherited neurodegenerative disorders result from polyglutamine expansions. Two recentl...
Abstract Protein kinases are critical modulators of a variety of cellular signal transduction pathwa...
Abstract The p38 mitogen-activated protein kinase (MAPK) pathway plays a key role in pathological gl...
Parkinson’s disease, the second major neurodegenerative disease, has created a great impact on the e...
Many neurodegenerative disorders, such as Alzheimer's, Parkinson's and polyglutamine diseases, share...
Many neurodegenerative disorders, such as Alzheimer's, Parkinson's and polyglutamine disea...
Mammalian p38 mitogen-activated protein kinases (MAPKs) are activated by a wide range of cellular st...
Polyglutamine diseases are neurodegenerative disorders caused by expansion of polyglutamine tracts i...
International audiencePolyglutamine diseases, including Huntington's disease , designate a group of ...
Polyglutamine expansion disorders are progressive neurodegenerative diseases that are caused by the ...
Mammalian p38 mitogen-activated protein kinases (MAPKs) are activated by a wide range of cellular st...
The signaling pathways that may modulate the pathogenesis of diseases induced by expanded polyglutam...
<p>Activation p38MAPK signaling is counteracted by PKCι-mediated ERK activation in expanded polyglut...
The history of polyglutamine diseases dates back approximately 20 years to the discovery of a polygl...
AbstractThe mechanisms of neurodegeneration in the CAG repeat polyglutamine diseases, including Spin...
AbstractNine inherited neurodegenerative disorders result from polyglutamine expansions. Two recentl...
Abstract Protein kinases are critical modulators of a variety of cellular signal transduction pathwa...
Abstract The p38 mitogen-activated protein kinase (MAPK) pathway plays a key role in pathological gl...
Parkinson’s disease, the second major neurodegenerative disease, has created a great impact on the e...
Many neurodegenerative disorders, such as Alzheimer's, Parkinson's and polyglutamine diseases, share...
Many neurodegenerative disorders, such as Alzheimer's, Parkinson's and polyglutamine disea...
Mammalian p38 mitogen-activated protein kinases (MAPKs) are activated by a wide range of cellular st...
Polyglutamine diseases are neurodegenerative disorders caused by expansion of polyglutamine tracts i...
International audiencePolyglutamine diseases, including Huntington's disease , designate a group of ...
Polyglutamine expansion disorders are progressive neurodegenerative diseases that are caused by the ...
Mammalian p38 mitogen-activated protein kinases (MAPKs) are activated by a wide range of cellular st...